Patient-Reported Safety Information: A Renaissance of Pharmacovigilance? - Wikidata - wikimedia - TriplyDB

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

http://www.wikidata.org/entity/Q48174494

about

Patient Reporting in the EU: Analysis of EudraVigilance Data.Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database

P2860

Q36349268-DEBC8953-A308-45A8-9890-C02E113663A4 Q37693933-1D3A7358-8928-4694-896D-39F0355665C3 Q39434726-71638119-172A-4385-8277-0346CA96F439 Q40144352-DCFD352B-747C-4270-BBBE-BFECF3FF8EF5 Q52664035-59C71F65-A013-485E-BA20-4BED6D41B0E4 Q52664572-A3FC0B7D-8EA2-4FA7-8BAE-E6A44899BCF1

P2860

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

http://www.wikidata.org/entity/Q48174494

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

@en

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

@nl

type

label

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

@en

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

@nl

prefLabel

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

@en

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

@nl

P1433

Q48174494-904D22CE-5B4C-4BB3-8AA2-54FF425266F3

P1476

Q48174494-5CF635C8-CF57-4FA6-8F2A-64D59F309A58

P2093

Q48174494-37130CB5-1E89-4844-874C-8B65E2517979

Q48174494-4F5BCDCB-236C-4984-80DA-87BAEB9D42A1

Q48174494-5E0A089C-E3C8-46FE-9DC8-55F16EF0A2C0

Q48174494-81770356-AB35-4E5A-811C-1CDEBC5898C6

Q48174494-E459E31B-0C3A-49E0-A4EE-14371CA2CD36

Q48174494-F46C892D-0FE3-4610-BA50-B41F73CF90B2

P2860

Q48174494-00632F2B-041D-4423-AE87-45251F365C90

Q48174494-0F1938B8-29C4-4757-AE8F-944CE7200815

Q48174494-2AAAA697-57DB-4CCC-9600-7F2E0732A423

Q48174494-37468BD2-50A9-43AB-94A9-CA62B6EB9066

Q48174494-39FCF536-7378-488C-BCC9-85E3F50CF99F

Q48174494-486117E0-F10F-43AB-9C1C-C0DF6719CBDA

Q48174494-505AFF7D-73EA-4E92-947B-51342D6BBC0B

Q48174494-577BD898-3B02-40E3-A8BC-38952A6EBF35

Q48174494-6FEF95EF-5F87-4D14-BC9D-2E250EFEDACE

Q48174494-72772200-5E50-4035-BBB1-B598CE42BA1D

P2888

Q48174494-72F78677-459F-4F9F-8F58-AD533DC6F634

P304

Q48174494-507C92F2-A766-44E1-83E6-AC46DA0B41EB

P31

Q48174494-D08B4116-108D-46B1-9165-ED4673E0CF35

P356

Q48174494-D9B29C38-EACB-45F5-B5AA-C304749C399A

P433

Q48174494-E3AA59F0-AE7D-47D1-B285-AF0BA2E548BB

P478

Q48174494-701F25D2-28D4-4B5E-8474-8451A732EE5F

P50

Q48174494-7A0696AC-FB5D-427C-AB69-9E8F7B6BA2C3

P577

Q48174494-680FBB8E-8F66-4D0D-8028-5CE35890ECEB

P698

Q48174494-E120493B-FF08-49CE-AAD7-54654B49A94A

P356

S40264-016-0441-X

P1433

P1476

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

@en

P2093

Agnes Kant

http://www.w3.org/2001/XMLSchema#string

Hubert Leufkens

http://www.w3.org/2001/XMLSchema#string

I Ralph Edwards

http://www.w3.org/2001/XMLSchema#string

June Raine

http://www.w3.org/2001/XMLSchema#string

Ugo Moretti

http://www.w3.org/2001/XMLSchema#string

Viola Macolic Sarinic

http://www.w3.org/2001/XMLSchema#string

P2860

Utilizing social media data for pharmacovigilance: A review

Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.

Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media.

Digital drug safety surveillance: monitoring pharmaceutical products in twitter

Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.

Sexual dysfunction, depression, and the impact of antidepressants.

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Social media and pharmacovigilance: A review of the opportunities and challenges.

Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study

P2888

s40264-016-0441-x

P304

883-890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40264-016-0441-X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27379887

http://www.w3.org/2001/XMLSchema#string